Home > Search Clinical Trials > All > Trial Details

Clinical Trial Details
Creatine Safety, Tolerability & Efficacy in Huntington’s Disease (CREST-E)
Clinical Trial ( IRB ) #: 10-016-1
Title: Creatine Safety, Tolerability & Efficacy in Huntington’s Disease (CREST-E)
Principal Investigator: Dr. Carolyn Drazinic
Description: The purpose of this research is to assess whether high doses of creatine can slow down the worsening of HD symptoms that occur over time. This research study is being undertaken in order that the Huntington Study Group develop a better understanding of side effects that can occur while taking long term creatine, assess its safety in long-term use and look at how creating affects the body and the brain.
Classification:
  Huntington's Disease
  Inherited/Congenital/Genetic
  Muscle, Bone and Cartilage
Eligibility Criteria: Check with study contact
How to Contact: Bonnie Hennig. Telephone: not available. Email: Hennig@uchc.edu